Get started
MODERNA, INCMODERNA, INCMODERNA, INC

MODERNA, INC

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

MRNA trade ideas

MODERNA has most likely bottomedModerna Inc (MRNA), a much discussed stock over the previous years, is having a +8% day, a very encouraging since following the rejection on the 1D MA50 (blue trend-line) three days ago. What's more interesting is that we have seen almost the same pattern in the stock's all time lows in 2019. As you see, the price since September has been on Lower Lows while the 1D RSI has been on Higher Lows, indicating a Bullish Divergence that is often seen on market bottoms before the price reverses. The very same Bullish Divergence was spotted from June 25 2019 until August 07 2019. It was also a remarkable 1D candle of +20% back then that signaled the sentiment shift. The price confirmed those bias when it broke above the 1D MA50. The break of the 1D MA200 (orange trend-line) a few days later opened the way for an incredible two year rise that was of course dominated by the COVID fundamentals mostly. It is worth noting that at the moment the 1D MA200 is too close to the 1D MA50 as opposed to 2019, so best to have our mark on the 1W MA100 (green trend-line) which has rejected both of 2022 uptrends in March 21 and August 04. It is exactly now where the 200.00 Resistance is (formed by the August 04 High). Also notice that the 1W MA200 (red trend-line) has made its appearance in October for the first time in history and provided the necessary Support for the early October push. ------------------------------------------------------------------------------- ** Please LIKE 👍, SUBSCRIBE ✅, SHARE 🙌 and COMMENT ✍ if you enjoy this idea! Also share your ideas and charts in the comments section below! This is best way to keep it relevant, support me, keep the content here free and allow the idea to reach as many people as possible. ** ------------------------------------------------------------------------------- You may also TELL ME 🙋‍♀️🙋‍♂️ in the comments section which symbol you want me to analyze next and on which time-frame. The one with the most posts will be published tomorrow! 👏🎁 ------------------------------------------------------------------------------- 👇 👇 👇 👇 👇 👇 💸💸💸💸💸💸 👇 👇 👇 👇 👇 👇
NASDAQ:MRNALong
by TradingShot
MRNA earnings 11/3 @ 7:15amMRNA Q3 September 2022 earnings are on 11/3 at 7:15am. Moderna (MRNA) reported Q2 June 2022 earnings of $5.24 per share on revenue of $4.7 billion. The consensus earnings estimate was $4.50 per share on revenue of $4.2 billion. Revenue grew 9.1% on a year-over-year basis. A possible long entry is dca 11/4 expiry otm calls the next week while everyone is focusing on Mega cap earnings week. Especially since MRNA pops on news and you don't know what day that will happen going into November. Q3 September 2022 Consensus: EPS = $4.83 Revenue = $5.13B P/E = 4 52week high = $376.75 52week low = $115.03 Do your own due diligence, your risk is 100% your responsibility. This is for educational and entertainment purposes only. You win some or you learn some. Consider being charitable with some of your profit to help humankind. Good luck and happy trading friends... *3x lucky 7s of trading* 7pt Trading compass: Price action, entry/exit Volume average/direction Trend, patterns, momentum Newsworthy current events Revenue Earnings Balance sheet 7 Common mistakes: +5% portfolio trades, capital risk management Beware of analyst's motives Emotions & Opinions FOMO : bad timing, the market is ruthless, be shrewd Lack of planning & discipline Forgetting restraint Obdurate repetitive errors, no adaptation 7 Important tools: Trading View app!, Brokerage UI Accurate indicators & settings Wide screen monitor/s Trading log (pencil & graph paper) Big, organized desk Reading books, playing chess Sorted watch-list Checkout my indicators: Fibonacci VIP - volume Fibonacci MA7 - price pi RSI - trend momentum TTC - trend channel AlertiT - notification tickerTracker - MFI Oscillator www.tradingview.com
NASDAQ:MRNALong
by Options360
MRNA harmonic 886 retracement. Interesting i article I found on the web on retracements. Different pattern but the idea is the same context. "short XA retracement particular, I realized that the B point within a Gartley-type structure that was less than a 0.618 would almost always exceed the expected 0.786 retracement of the XA leg at the projected completion point. I showed Jim this new pattern — called “the Bat” — which used what I was calling a “deep 0.786 retracement.” I told him that executing at the 0.786 without regard to the structure was a critical mistake. Besides, the 0.886 retracement, when used in the correct pattern structures, reduced the amount of risk in previously “undifferentiated” Gartley set-ups by 10 percent." old.harmonictrader.com I hope you enjoy the TA.
NASDAQ:MRNALong
by ryanmwing90878
$MRNA - Head & Shoulders + Double Top continuation baseKey intakes: - Head & Shoulder Pattern (m). - Double Top Pattern (w), as the right shoulder of the above. - No breakout yet to confirm both. - Are you sure you want to short this market with so much congestion underneath? - Are you sure you want to go along with so much bearish presence? - Immaculate example of how an uptrend can be captured with just: 1. A breakout from the IPO base; 2. A 10 EMA (m) trailing the price; 3. A ***tload of discipline and confidence in your system earned through countless hours of chart time, backtesting and a lot of golden teeth.
NASDAQ:MRNA
by ruben_rodrigues
Moderna at key resistance? Moderna Short Term We look to Sell at 183.71 (stop at 203.39) Preferred trade is to sell into rallies. Previous resistance located at 190.00. Trading within a Bearish Channel formation. Our overall sentiment remains bearish looking for lower levels. The bias is still for lower levels and we look for any gains to be limited. Our profit targets will be 121.74 and 94.19 Resistance: 190.00 / 220.00 / 495.00 Support: 156.00 / 120.00 / 100.00 Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features. Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
NASDAQ:MRNAShort
by Saxo